Resources

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (September 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

Presentations from the 2019 MS Summit

View Presentations here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (June 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (April 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

MS Coalition Brochure (January 2012)

The Multiple Sclerosis Coalition (MSC) was founded in 2005 by three independent multiple sclerosis (MS) organizations in an effort to work together to benefit individuals with MS. Since that time, the MSC has grown to nine member organizations, all of whom provide critical MS programs and services.    Download here

Follow us on Twitter

TwitterFollow

MS Coalition
Retweet on TwitterMS Coalition Retweeted
mssocietyNational MS Society@mssociety·
21 Jul

More than half of people living with #MultipleSclerosis experience mood changes at some point in the course of their disease. Learn how cognitive behavioral therapy can help you manage your emotions, as well as pain and fatigue: https://ntlms.org/HeadSpace.

Reply on Twitter 1285661122645893120Retweet on Twitter 12856611226458931206Like on Twitter 128566112264589312027Twitter 1285661122645893120
Retweet on TwitterMS Coalition Retweeted
CanDoMSCan Do MS@CanDoMS·
21 Jul

Visit our MS Drug Access resource page to explore how you CAN overcome barriers and make informed treatment decisions with your healthcare team.

https://www.cando-ms.org/online-resources/accessing-ms-drugs-healthcare

Reply on Twitter 1285704313470365697Retweet on Twitter 12857043134703656972Like on Twitter 12857043134703656971Twitter 1285704313470365697
Retweet on TwitterMS Coalition Retweeted
MSassociationMS Assoc. of America@MSassociation·
22 Jul

We provide a toll-free Helpline that allows members of the MS community to speak directly with one of MSAA’s experienced specialists. These trained and compassionate individuals have a social services and/or counseling background. To learn more, visit: https://mymsaa.org/msaa-help/helpline-chat/

Reply on Twitter 1285925012336267266Retweet on Twitter 12859250123362672661Like on Twitter 12859250123362672665Twitter 1285925012336267266
Load More...